Literature DB >> 14967313

Additional evidence of acute anti-inflammatory effects of cyclosporin A in a murine model of pleurisy.

Eduardo Monguilhott Dalmarco1, Tânia Silvia Fröde, Yara Santos Medeiros.   

Abstract

INTRODUCTION: It is well known that cyclosporin A (CsA) exhibits important anti-inflammatory effects, besides its immunosuppressive activity. However, the mechanisms by which CsA exerts these effects remain unclear.
OBJECTIVE: This study evaluated whether the acute administration of CsA significantly interfered in leukocyte migration, exudation, myeloperoxidase (MPO) and adenosine-deaminase activities and nitrate/nitrite levels, in a mouse model of pleurisy.
MATERIALS AND METHODS: Pleurisy was induced by carrageenan (1%) treatment and the parameters were analyzed 4 and 48 h after. Groups of animals were previously treated with different doses of CsA and compared with non-treated groups.
RESULTS: CsA (0.1-5 mg/kg, intraperitoneal, 1 h before pleurisy induction) inhibited neutrophil migration (P<0.05), but not the exudation that occurred 4 h after pleurisy induction. At this time, CsA (1 mg/kg, 1 h before) also decreased nitrate/nitrite levels and MPO activity (P<0.01). CsA (2 mg/kg, 0.5 h before) was also effective in decreasing mononuclear influx, exudation and nitrate/nitrite levels 48 h after onset of inflammation.
CONCLUSIONS: These results indicate that the acute administration of CsA is able to reduce the two leukocyte populations that occur both at 4 and 48 h after pleurisy induction, late exudation (48 h), MPO activity (4 h) and nitrate/nitrite levels (4 and 48 h). Taken together, these findings indicate that CsA has acute anti-inflammatory effects in immunocompetent animals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14967313     DOI: 10.1016/j.trim.2003.09.001

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  6 in total

1.  A Novel Tetrasubstituted Imidazole as a Prototype for the Development of Anti-inflammatory Drugs.

Authors:  Marcus Vinicius P S Nascimento; Antonio C M Munhoz; Lais C Theindl; Eduarda Talita B Mohr; Najla Saleh; Eduardo B Parisotto; Thaís A Rossa; Ariane Zamoner; Tania B Creczynski-Pasa; Fabíola B Filippin-Monteiro; Marcus M Sá; Eduardo Monguilhott Dalmarco
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

2.  PPAR-gamma agonist rosiglitazone attenuates the inflammation caused by carrageenan in the mouse model of pleurisy.

Authors:  Ziliani da Silva Buss; Yara S Medeiros; Tania S Fröde
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

3.  Steering the Clinical Translation of Delivery Systems for Drugs and Health Products.

Authors:  Rosario Pignatello; Pietro Matricardi
Journal:  Pharmaceutics       Date:  2020-04-13       Impact factor: 6.321

4.  Cyclosporin A inhibits CD11a/CD18 adhesion molecules due to inhibition of TNFalpha and IL-1 beta levels in the mouse model of pleurisy induced by carrageenan.

Authors:  Eduardo Monguilhott Dalmarco; Yara Santos Medeiros; Tânia Silvia Fröde
Journal:  Cell Adh Migr       Date:  2008-10-23       Impact factor: 3.405

5.  Cyclosporine A Promotes Bone Remodeling in LPS-Related Inflammation via Inhibiting ROS/ERK Signaling: Studies In Vivo and In Vitro.

Authors:  Yuwei Zhao; Jing Gao; Yarong Zhang; Xueqi Gan; Haiyang Yu
Journal:  Oxid Med Cell Longev       Date:  2021-01-07       Impact factor: 6.543

6.  Evaluation of cytotoxic and anti-inflammatory activities of extracts and lectins from Moringa oleifera seeds.

Authors:  Larissa Cardoso Corrêa Araújo; Jaciana Santos Aguiar; Thiago Henrique Napoleão; Fernanda Virgínia Barreto Mota; André Luiz Souza Barros; Maiara Celine Moura; Marília Cavalcanti Coriolano; Luana Cassandra Breitenbach Barroso Coelho; Teresinha Gonçalves Silva; Patrícia Maria Guedes Paiva
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.